Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:603108'
s Days Payable Range Over the Past 10 Years
Min: 33.31 Med: 67.73 Max: 90.81
Current: 82.8
During the past 13 years, Shanghai Runda Medical Technology Co's highest Days Payable was 90.81. The lowest was 33.31. And the median was 67.73.
SHSE:603108's Days Payable is ranked better than 57.37% of 190
companies
in the Medical Diagnostics & Research industry
Industry Median: 64.945
vs SHSE:603108: 82.80
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Runda Medical Technology Co Days Payable Chart
SHSE:603108 vs TMO, DHR, IDXX: Days Payable Comparison
For the Diagnostics & Research subindustry, Shanghai Runda Medical Technology Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Runda Medical Technology Co Days Payable vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Shanghai Runda Medical Technology Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Shanghai Runda Medical Technology Co's Days Payable falls into.
Shanghai Runda Medical Technology Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Runda Medical Technology Co (SHSE:603108) has a Days Payable of 87.51 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Shanghai Runda Medical Technology Co and its competitors. This is 29% above median its historical median of 67.73. Over the past decade, Shanghai Runda Medical Technology Co's Days Payable has ranged from 33.31 to 90.81. According to the industry distribution chart, Shanghai Runda Medical Technology Co ranks #81 out of 190 companies in the Medical Diagnostics & Research industry, placing it in the top 42.6%.
Is Shanghai Runda Medical Technology Co's Days Payable too high?
Shanghai Runda Medical Technology Co's current Days Payable of 87.51 is 29% above median its 10-year median of 67.73. Over the past 10 years, this metric has ranged from a low of 33.31 to a high of 90.81. The Medical Diagnostics & Research industry median Days Payable is 64.95. Shanghai Runda Medical Technology Co's value of 87.51 is 34.7% above this industry median. Based on the distribution chart, Shanghai Runda Medical Technology Co ranks #81 out of 190 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Shanghai Runda Medical Technology Co has a GF Score™ of 39/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Shanghai Runda Medical Technology Co's Days Payable compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Shanghai Runda Medical Technology Co ranks #81 out of 190 companies for Days Payable. This puts Shanghai Runda Medical Technology Co in the upper half of its industry. The industry median Days Payable is 64.95. Shanghai Runda Medical Technology Co's value of 87.51 is 34.7% above this benchmark. Historically, Shanghai Runda Medical Technology Co's own Days Payable has ranged from 33.31 to 90.81 over the past decade. While the company's 10-year median is 67.73 vs. the industry median of 64.95, Shanghai Runda Medical Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Diagnostics & Research company?
The median Days Payable among Medical Diagnostics & Research companies is 64.95, based on 190 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Runda Medical Technology Co's current Days Payable of 87.51 is 34.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Shanghai Runda Medical Technology Co and its competitors. For the Medical Diagnostics & Research industry, the median Days Payable is 64.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Runda Medical Technology Co's current Days Payable is 87.51, which is 29% above median its own 10-year median of 67.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Runda Medical Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Runda Medical Technology Co (SHSE:603108) is currently considered Possible Value Trap. The stock's GF Value™ is ¥17.89, compared to a current price of ¥10.01 — trading 44% below its estimated fair value. The current Days Payable is 87.51, which is 29% above median its 10-year median of 67.73 and 34.7% above the Medical Diagnostics & Research industry median of 64.95. Shanghai Runda Medical Technology Co's overall GF Score™ is 39/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Shanghai Runda Medical Technology Co (SHSE:603108), the current Days Payable is 87.51 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Runda Medical Technology Co (SHSE:603108) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Runda Medical Technology Co stock appears to be undervalued.
The current stock price of ¥10.01 is trading 44% below its estimated GF Value™ of ¥17.89.
GuruFocus considers Shanghai Runda Medical Technology Co to be Possible Value Trap.
Key valuation signals for SHSE:603108:
Days Payable: 87.51 (29% above median its 10-year median of 67.73)
GF Value™: ¥17.89 vs. price of ¥10.01 (44% below fair value)
Industry Position: 34.7% above the Medical Diagnostics & Research median (#81 of 190)
No single metric tells the full story. See the SHSE:603108 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Runda Medical Technology Co Ltd is a medical laboratory integrated service provider based in East China. The company provides in-vitro diagnostic products and professional technical support to various medical laboratories.
39GF Score
Get the complete analysis for SHSE:603108
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603108 has been successfully added to your 
